2022 ICD-10-CM Code C79.63

Secondary malignant neoplasm of bilateral ovaries

Version 2021

Valid for Submission

ICD-10:C79.63
Short Description:Secondary malignant neoplasm of bilateral ovaries
Long Description:Secondary malignant neoplasm of bilateral ovaries

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
      • Secondary malignant neoplasm of other and unspecified sites (C79)

C79.63 is a billable diagnosis code used to specify a medical diagnosis of secondary malignant neoplasm of bilateral ovaries. The code C79.63 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.

The code C79.63 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

New 2022 ICD-10 Code

C79.63 is new to ICD-10 code set for the FY 2022, effective October 1, 2021. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2021. This is a new and revised code for the FY 2022 (October 1, 2021 - September 30, 2022).

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

Replacement Code

C7963 replaces the following previously assigned ICD-10 code(s):

Code History